Name: Drugged Driving Expert Panel Report: A Consensus Protocol for Assessing the Potential of Drugs to Impair Driving (en Inglés)
Price: 427.56 MXN
Availability: InStock
Author: National Highway Traffic Safety Administ
ISBN: 9781501005480

Envío gratis

portada Drugged Driving Expert Panel Report: A Consensus Protocol for Assessing the Potential of Drugs to Impair Driving (en Inglés)

Formato

Libro Físico

Autor

National Highway Traffic Safety Administ

Editorial

Createspace Independent Publishing Platform

Idioma

Inglés

N° páginas

Encuadernación

Tapa Blanda

Dimensiones

28.0 x 21.6 x 0.1 cm

Peso

0.09 kg.

ISBN13

9781501005480

Categorías

Bibliografias

Drugged Driving Expert Panel Report: A Consensus Protocol for Assessing the Potential of Drugs to Impair Driving (en Inglés)

National Highway Traffic Safety Administ (Autor) · Createspace Independent Publishing Platform · Tapa Blanda

Libro Nuevo

$ 427.56

$ 777.38

Ahorras: $ 349.82

45% descuento

Envío normal

Origen: Estados Unidos (Costos de importación incluídos en el precio)

Se enviará desde nuestra bodega entre el Jueves 08 de Agosto y el Miércoles 21 de Agosto.

Lo recibirás en cualquier lugar de México entre 1 y 3 días hábiles luego del envío.

Reseña del libro "Drugged Driving Expert Panel Report: A Consensus Protocol for Assessing the Potential of Drugs to Impair Driving (en Inglés)"

In November 2008 and again in March 2009, an expert panel was convened by the National Highway Traffic Safety Administration with the goal of determining whether a list could be developed to indicate which medications or classes of medications may pose a hazard to driving. There was particular interest in having the panel develop a list of "safe" medications that do not impair driving. The value of the list would be to better inform patients and physicians regarding the likely effects of a drug on driving. This information could lead to better-informed prescribing practices and to more rational selection of medications by patients. The panel was composed of an international group of behavioral scientists, epidemiologists, pharmacologists, toxicologists, and traffic safety professionals to provide a broad-based perspective on the issue. Discussions included prescription (Rx) medications as well as over-the-counter (OTC) medications and illicit drugs. Although illicit drugs are best known for their impairing effects, Rx and OTC medications are also known to be capable of producing impairment and many are frequently encountered in impaired driver populations. The panel agreed that one of the barriers to categorizing drugs with respect to driving impairment risk is the lack of a common, standardized protocol for assessing the impairing potential of drugs. The panel recognized the need for a structured, standardized protocol for assessing the driving impairment risk of drugs that would lead to better classification of drugs in terms of driving impairment risk. The approach could be useful in providing more meaningful precautions for users and prescribers regarding the impact of drugs on driving. This report provides the background for the project and assembly of the expert panel, a description of the proposed protocol, and offers examples of how the protocol could be useful in evaluating a drug.